Evaluating the risk factors for liver injury in patients with chronic lymphocytic leukemia in the dynamics of chemotherapy
Journal Title: Гастроентерологія - Year 2019, Vol 53, Issue 2
Abstract
Background. B-cell chronic lymphocytic leukemia (B-CLL) treatment is accompanied by a risk of liver injury due to factors that depend on the characteristics of the patient, tumor, and chemotherapy (CT). The purpose was to assess the risk of development and nature of liver injury in patients with B-CLL in the dynamics of CT. Materials and methods. Seventy-six patients with В-CLL were examined, including 44 (57.9 %) men and 32 (42.1 %) women. The average age was (66.81 ± 12.50) years. The B-CLL stage was determined according to the Rai (1975, 1987) and Binet (1981, 2006) classifications. CT was administered in FC (fludarabine, cyclophosphamide) regimen. The patients were examined twice: before CT and after two FC courses. Hyperplastic syndrome and hyperleukocytosis were taken into account. Biochemical blood tests were evaluated. Common Terminology Criteria for Adverse Events, version 4.02, were used. Results. Advanced B-CLL stages (stage IV (C) according to Rai, Binet) are associated with an increased risk of no response on CT (risk ratio (RR) = 0.53; 95% confidence interval (CI) = 0.31–0.90; p < 0.05). The presence of hyperplastic syndrome is accompanied by a significant risk of no response on CT (RR = 0.23; 95% CI = 0.07–0.80; p < 0.05). Liver injury is more often detected in patients with B-CLL stages III (RR = 1.96; 95% CI = 1.33–2.88; p < 0.05) and IV (RR = 2.13; 95% CI = 1.47–3.08; p < 0.05) versus stage II by Rai. In patients with B-CLL, the risk of hepatotoxic reactions development is associated with low efficacy of CT, namely the achievement of partial response (RR = 3.18; 95% CI = 1.93–5.22; p < 0.05) and no response on CT (RR = 3.71; 95% СІ = 2.37–5.81; р < 0.05). Conclusions. The risk of liver injury increases in patients with B-CLL stage IV (C) and is associated with low CT efficacy.
Authors and Affiliations
G. S. Maslova, I. M. Skrypnyk
Keywords
Related Articles
- EP ID EP582154
- DOI 10.22141/2308-2097.53.2.2019.168986
- Views 65
- Downloads 0
The Role of Enteropathogenic E.coli in the Development and Progression of Chronic Non-Ulcerative Colitis
Objective. The analysis of the literature has shown that in patients with chronic non-ulcerative colitis, there were isolated E.coli that cause dysentery-like, cholera-like diseases and escherichioses. Thus, the aim of o...
Pathogenic Role of Nitric Oxide in Formation of Different Types of Gastroesophageal Reflux Disease in Servicemen
The article presents a literature review and analysis of the results of our studies on pathogenic role of nitric oxide in formation of different types of gastroesophageal reflux disease among servicemen taking into accou...
Comprehensive therapy of gastroesophageal reflux disease combined with anxiety-depressive states in antiterrorist operation participants
Background. The purpose was to establish the incidence and severity of anxiety-depressive disorders in antiterrorist operation (ATO) participants with different clinical endoscopic forms of gastroesophageal reflux diseas...
Physiological Needs of the Body in Essential Minerals and the Role of Water Factor in Their Provision (in Terms of Some Rural Districts of Odesa Region)
The investigation of the mineral substances intake to the body of the residents in six districts of the Odesa region distinct by the conditions of water supply has been done. It has been found that nutrition of the popul...
Bacterial overgrowth syndrome in patients with chronic diffuse liver diseases depending on the etiology and morphological features
Background. Previous studies have shown an increased risk of liver disease in intestinal dysbiosis. Damage to the liver in itself can be the cause of the bacterial overgrowth syndrome. It has been proven that bacterial o...